Kim Callender, NP, FNP-BC
Lead Clinical Reviewer
Kim Callender, FNP-BC is a board-certified family nurse practitioner and the lead clinical reviewer for Tirzepatide Watchdog. She reviews patient-journey, clinical-workflow and care-model content: intake quality, prescriber review processes, follow-up access, refill workflows and support escalation. Her NPI record (1144661760) is listed in the CMS NPPES registry.
Credentials & verification
- Role
- Lead Clinical Reviewer
- NPI
- 1144661760 — verified in the CMS National Plan & Provider Enumeration System registry
- Review scope
- Clinical workflow and patient-care review: provider reviews, care-model comparisons, support testing.
- Verification
- NPI record checked against the CMS NPPES registry.
Conflict disclosure
Kim Callender, NP, FNP-BC is not compensated based on any reviewed provider's sales. Where a page involves NexLife, our ownership relationship is disclosed on that page, and the NexLife score is signed off by an unaffiliated reviewer. See our conflicts-of-interest policy.
Jastreboff AM et al., N Engl J Med 2022 (NCT04184622), n=2,539. Dose-response is real: the effect rises with dose. These are FDA-APPROVED SUBCUTANEOUS INJECTION doses — they do not transfer to compounded, microdose or ODT products. Trial means are not individual promises.
Role and scope
Kim Callender, NP, FNP-BC — Lead Clinical Reviewer. NPI 1144661760, verified against the CMS National Plan and Provider Enumeration System.
Kim Callender writes and reviews clinical content: mechanism of action, dosing and titration, side effects, contraindications, drug interactions and monitoring. She reviews every page that describes what a medication does to the body.
What we publish, and what we deliberately do not
This profile contains only information that has been confirmed to us. We publish the name, the credential, the editorial role, the scope of review, and — where it exists — an NPI that we have checked against the CMS registry.
We do not publish specialty, board certification, state licence, hospital affiliation, university affiliation, awards, professional memberships, or biography unless each has been separately verified. Padding a reviewer profile with unverified professional detail is one of the commonest ways a health site manufactures authority, and we would rather this page look thin than look impressive on facts we cannot stand behind.
Conflict disclosure
Relationships the publisher has confirmed to date: NexLife (financial interest). Where a provider is not named here, that is because the publisher has not confirmed a relationship — it is not a statement that we have verified its absence. We would rather show you that gap than imply an independence we have not checked.
Compensation does not increase the price you pay, and does not permit any provider to purchase a verification status, alter a documented fact, remove a material limitation, change a ranking, or bypass our published editorial and medical-review standards.
No reviewer on this site is compensated based on any provider’s sales, and no employee, executive or medical director of any reviewed provider writes, reviews, scores or approves that provider’s page. NexLife’s medical director, Dr. Adam Kennah, has no role in our editorial process. We name him on the NexLife review because he is a fact about NexLife — not because he has anything to do with our independence.